Mast cells as possible targets of propranolol therapy: an immunohistological study of beta-adrenergic receptors in infantile haemangiomas

Histopathology. 2014 Sep;65(3):436-9. doi: 10.1111/his.12421. Epub 2014 Jun 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Child
  • Child, Preschool
  • Hemangioma, Capillary / drug therapy*
  • Hemangioma, Capillary / metabolism*
  • Hemangioma, Capillary / pathology
  • Humans
  • Immunohistochemistry
  • Infant
  • Mast Cells / drug effects*
  • Mast Cells / metabolism
  • Mast Cells / pathology
  • Propranolol / pharmacology*
  • Receptors, Adrenergic, beta / metabolism*
  • Receptors, Adrenergic, beta-1 / metabolism
  • Receptors, Adrenergic, beta-2 / metabolism
  • Receptors, Adrenergic, beta-3 / metabolism

Substances

  • ADRB1 protein, human
  • ADRB2 protein, human
  • ADRB3 protein, human
  • Adrenergic beta-Antagonists
  • Receptors, Adrenergic, beta
  • Receptors, Adrenergic, beta-1
  • Receptors, Adrenergic, beta-2
  • Receptors, Adrenergic, beta-3
  • Propranolol